Literature DB >> 12325019

Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening?

Birgitta Winnepenninckx1, Vanessa Errijgers, France Hayez-Delatte, Edwin Reyniers, R Frank Kooy.   

Abstract

Mutations in the methyl-CpG-binding protein 2 (MECP2) cause Rett syndrome, a severe neurodevelopmental disorder occurring predominantly in females. Male patients with Rett syndrome are extremely rare, as the Rett-causing mutations in the MECP2 gene are usually lethal in hemizygous males. However, different mutations in the same gene were reported to cause mental retardation, both in sporadic non-syndromic males as well as in syndromic families with disease manifestation in carrier females. The majority of the reported MECP2 mutations in mentally retarded patients cause amino acid substitutions and, especially in isolated cases, discrimination between a disease-causing mutation and a rare polymorphism is not obvious and the significance of each individual variation should be verified. We mapped a new non-syndromic X-linked family (MRX79) to the chromosomal region Xq27.3-Xq28 and identified an A140V mutation in the MEPC2 gene in all patients with the disease haplotype. In addition to data published by others, this suggests that A140V is a recurrent mutation (and not a polymorphism) found in patients with X-linked mental retardation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325019     DOI: 10.1002/humu.10130

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.

Authors:  Jeffrey L Neul; Timothy A Benke; Eric D Marsh; Steven A Skinner; Jonathan Merritt; David N Lieberman; Shannon Standridge; Timothy Feyma; Peter Heydemann; Sarika Peters; Robin Ryther; Mary Jones; Bernhard Suter; Walter E Kaufmann; Daniel G Glaze; Alan K Percy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-07       Impact factor: 3.568

Review 2.  Rett syndrome: disruption of epigenetic control of postnatal neurological functions.

Authors:  Amy E Pohodich; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2015-06-09       Impact factor: 6.150

Review 3.  MECP2 mutations in males.

Authors:  Laurent Villard
Journal:  J Med Genet       Date:  2007-03-09       Impact factor: 6.318

4.  Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Authors:  Garilyn M Jentarra; Shannon L Olfers; Stephen G Rice; Nishit Srivastava; Gregg E Homanics; Mary Blue; Sakkubai Naidu; Vinodh Narayanan
Journal:  BMC Neurosci       Date:  2010-02-17       Impact factor: 3.288

5.  A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.

Authors:  Rodney C Samaco; John D Fryer; Jun Ren; Sharyl Fyffe; Hsiao-Tuan Chao; Yaling Sun; John J Greer; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

Review 6.  Rett syndrome: the complex nature of a monogenic disease.

Authors:  Alessandra Renieri; Ilaria Meloni; Ilaria Longo; Francesca Ariani; Francesca Mari; Chiara Pescucci; Franca Cambi
Journal:  J Mol Med (Berl)       Date:  2003-05-16       Impact factor: 4.599

Review 7.  The relationship of Rett syndrome and MECP2 disorders to autism.

Authors:  Jeffrey Lorenz Neul
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986

8.  TM4SF10 gene sequencing in XLMR patients identifies common polymorphisms but no disease-associated mutation.

Authors:  Christiane Christophe-Hobertus; Frank Kooy; Jozef Gecz; Marc J Abramowicz; Elke Holinski-Feder; Charles Schwartz; Daniel Christophe
Journal:  BMC Med Genet       Date:  2004-09-02       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.